Показано 0 из 0
Дата |
---|
09.02.2024 |
08.02.2024 |
07.02.2024 |
06.02.2024 |
05.02.2024 |
02.02.2024 |
01.02.2024 |
31.01.2024 |
30.01.2024 |
29.01.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
28.74
|
29.19
|
28.89
|
28.89
|
28.99
|
28.96
|
|
|
|
|
28.76
|
29.21
|
27.41
|
27.41
|
29.04
|
28.98
|
|
|
2 879.00
|
19.00
|
27.28
|
27.70
|
27.43
|
27.37
|
27.54
|
27.49
|
|
|
|
|
27.24
|
27.66
|
27.24
|
27.24
|
27.45
|
27.45
|
|
|
|
|
27.12
|
27.54
|
27.11
|
27.09
|
27.34
|
27.33
|
|
|
|
|
27.03
|
27.45
|
27.01
|
26.94
|
27.29
|
27.17
|
|
|
|
|
26.82
|
27.23
|
27.14
|
27.02
|
27.21
|
27.02
|
|
|
|
|
26.86
|
27.28
|
27.17
|
27.00
|
27.22
|
27.06
|
|
|
540.00
|
19.00
|
26.94
|
27.36
|
27.26
|
27.14
|
27.29
|
27.15
|
|
|
|
|
27.00
|
27.42
|
27.11
|
27.11
|
27.38
|
27.12
|
|
|
|
|
ImmunoGen, Inc., a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate (ADC) technology.